Physician profile
Anthony Yin
NPI 1982710976
$460.90
in general payments reported to CMS, 2019-2025
13 companies · $27.20 in 2025
The $27.20 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2022: $19.38 · 2023: $155 · 2024: $20.52 · 2025: $27.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $203.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $99.11 | 2023 | Minimed 780g |
| Dexcom, INC. | $64.31 | 2019-2024 | Dexcom G6 Transmitter |
| Insulet Corporation | $61.27 | 2019-2022 | |
| Lilly USA, LLC | $42.67 | 2019 | |
| Mannkind Corporation | $27.36 | 2019 | |
| Sequel Med Tech, LLC | $27.20 | 2025 | Twiist |
| Beta Bionics, INC. | $23.08 | 2023 | Ilet Bionic Pancreas |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.22 | 2019 | |
| Companion Medical, INC. | $21.66 | 2019 | |
| Novo Nordisk INC | $20.16 | 2019 | |
| Abbott Laboratories | $18.62 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.00 | 2023 | |
| Tandem Diabetes Care, INC. | $15.24 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Yin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.